Powerful Data Potentiates Rapid EU Market Approval For Tigenix Stem Cell Therapies – Seeking Alpha
Seeking Alpha |
Powerful Data Potentiates Rapid EU Market Approval For Tigenix Stem Cell Therapies
Seeking Alpha Their lead candidate, Cx601, now known in the EU market as Alofisel, is an adipose derived stem cell product designed to treat Crohn's disease related fistulas. They have recently seen success associated with their lead product and are expecting a CHMP … ETHICS AND RESEACRCH VERSUS EMBRYONIC STEM CELL |
